FDA Inspection 1240413 — Department Of Defense - Navy
The FDA completed an inspection of Department Of Defense - Navy on May 2, 2024 in Guantanamo Bay. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- May 2, 2024
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Guantanamo Bay (Cuba)